You are here
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
SBC: Physical Optics Corporation Topic: DHP163004
To address the DHP need for a novel self-propelled tick collection device that is capable of operating in diverse habitats under various environmental conditions, Physical Optics Corporation (POC) proposes to develop a new Multifunctional Automated Tick-Collection Rover (MATR) based on a novel system design, and mature COTS and in-house components. MATR is a configurable lightweight autonomous all ...SBIR Phase I 2017 Department of DefenseDefense Health Agency
Improved Human Machine Interface Usability for Clinical Healthcare Providers to Enter Data into Electronic Health RecordsSBC: BIO1 SYSTEMS, Inc. Topic: DHP163001
Nowhere are limitations in the Electronic Health Record (EHR) more evident than within the first critical periods of care (the golden hour)from injury presentation, primary survey, stabilization, secondary survey, transportation, triage, and medical facility admission. Despite the commencement of clinical care, EHR limitations prevent much of this information from being captured and shared. In mil ...SBIR Phase I 2017 Department of DefenseDefense Health Agency
SBC: CRITICAL INNOVATIONS LLC Topic: DHA17010
Defense Health Program (DHP) seeks to develop a new and innovative point of injury device to manage patients with moderate-to-severe Traumatic Brain Injury (TBI). Critical Innovations, NeoMatRx, and KARA & Associates, with consultants Captain David Plurad, MD, FACS (USN, Ret.) and neurosurgeon Michael Levy, MD, PhD., have formed a team of medical device, trauma, and neurosurgical experts to addres ...SBIR Phase I 2017 Department of DefenseDefense Health Agency
SBC: INNOSENSE CORPORATION Topic: CBD181004
Chemical warfare agents such as the lethal nerve agent soman are a major source of risk to military personnel. Currently, pyridostigmine bromide (PB) is the only FDA-approved pretreatment to counteract the effects of soman. The rationale behind PB administration is that it acts as a “temporary” inhibitor of AChE. This precludes nerve agents from irreversible inactivation of AChE, thereby mitig ...SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
Local Patient Record Transfer Modernization in Theater/Operational Settings in Support of JOMIS Patient Movement Requirements Definition Package (RDP) RequirementsSBC: TOYON RESEARCH CORPORATION Topic: DHP191003
As the production of products with wirelesscapabilities like WiFiand Bluetooth are nearly becomingastandard, it offers the opportunity to drop thearchaicmethods to transfer data between devices with technology like CDsand offerasimpler way for military medics to exchange patient information. Toyon Research Corporation proposes DropNet,across-platform application for secure, device-to-device(D2D)me ...SBIR Phase I 2019 Department of DefenseDefense Health Agency
SBC: HITRON TECHNOLOGIES INC Topic: DHP163004
Leveraging on our expertise in electro-opto-mechanical device development and system integration (hardware and software), Hitron Technologies Inc. (HTI) proposes to develop an autonomous solution tentatively named Tick Collection Robot (TiCoBot). The TiCoSBIR Phase I 2017 Department of DefenseDefense Health Agency
Sequential Phase II Proposal for Smartphone Application for Mask Sizing and Projecting Quantitative FitSBC: Physical Optics Corporation Topic: CBD181006
To address the Chemical and Biological Defense (CBD) need for a field-portable mass spectrometer for small molecule drugs in clinical samples, Physical Optics Corporation (POC) proposes to develop a new FiEldable DRug Mass Analysis (FERMA) system based on a combination of portable mass spectrometry technology with laser desorption/ionization for use with aqueous clinical samples. The FERMA system ...SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
SBC: Physical Optics Corporation Topic: DHA17009
To address the DHA need for a new treatment approach for osteochondral defects that is able to conform to a wide range of complex geometries, Physical Optics Corporation (POC) proposes to develop a new Conformable Orthopaedic Repair Approach (CORA). It is based on minimally invasive delivery of a gel that can be stabilized in situ at the defect site. Specifically, the innovation in our approach is ...SBIR Phase I 2017 Department of DefenseDefense Health Agency
SBC: Physical Optics Corporation Topic: CBD171004
To address the DoDs Chemical and Biological Defense (CBD) program need for the development of real-time analytical technology for multicomponent vapor identification and quantification, Physical Optics Corporation (POC) proposes to develop a new Photoacoustic Gasses Optical Detector and Analyzer (PAGODA). It is based on a new system design that utilizes a novel, POC-developed photoacoustic transdu ...SBIR Phase I 2017 Department of DefenseOffice for Chemical and Biological Defense
SBC: CHEMELECTRONICS LLC Topic: DTRA182007
In this project, we propose to identify and examine solution growth approaches for engineering perovskite single crystal for gamma spectrometry in a hand-held sensor format. We will demonstrate that the solution growth approach is able to produce perovskite single crystal in sufficient volume and quality to yield a detector crystal whose utilization presents no inherent environmental, health, or s ...SBIR Phase I 2019 Department of DefenseDefense Threat Reduction Agency